Uro-News

, Volume 18, Issue 4, pp 34–44

Placeboeffekte und ihre Implikationen in der Medizin

Positive Erwartung, Konditionierung, Lernprozess
Zertifizierte Fortbildung

Zusammenfassung

Aktuelle neurowissenschaftliche und klinische Befunde zu positiven physiologischen oder psychologischen Veränderungen nach Einnahme von Medikamenten ohne spezifische Wirkstoffe oder Scheineingriffen haben wichtige Implikationen für die praktische Behandlung. Diese „Placeboeffekte“ sind zum Beispiel für Patienten mit erektiler Dysfunktion relevant. Die Wirksamkeit von PDE5-Inhibitoren ist zwar eindeutig nachgewiesen, dennoch macht sich bei dieser Substanzklasse eine ausgesprochen hohe Placeborate bemerkbar.

Literatur

  1. 1.
    Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nature reviews Drug discovery. 2013;12(3):191–204. Epub 2013/03/02.Google Scholar
  2. 2.
    Klinger R. [The potential of the analgetic placebo effect — s3-guideline recommendation on the clinical use for acute and perioperative pain management]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;45(1):22–9. Epub 2010/01/22. Das Potenzial des analgetischen Placeboeffektes — S3-Leitlinien-Empfehlung zur Behandlung akuter und perioperativer Schmerzen. rklinger@uni-hamburg.de.PubMedCrossRefGoogle Scholar
  3. 3.
    Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19(1):484–94.PubMedGoogle Scholar
  4. 4.
    Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315–23.PubMedGoogle Scholar
  5. 5.
    Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, et al. Behavioral conditioning of immunosuppression is possible in humans. Faseb J. 2002;16(14):1869–73.PubMedCrossRefGoogle Scholar
  6. 6.
    Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain. 2002;99(3):443–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594–602.PubMedCrossRefGoogle Scholar
  8. 8.
    Vase L, Petersen GL, Riley JL, 3rd, Price DD. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain. 2009;145(1–2):36–44.PubMedCrossRefGoogle Scholar
  9. 9.
    Krogsboll LT, Hrobjartsson A, Gotzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC medical research methodology. 2009;9:1. Epub 2009/01/07.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Rutherford BR, Mori S, Sneed JR, Pimontel MA, Roose SP. Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review. Journal of psychiatric research. 2012;46(6):697–702. Epub 2012/03/14.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2(8091):654–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Eippert F, Finsterbusch J, Bingel U, Buchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science. 2009;326(5951):404.PubMedCrossRefGoogle Scholar
  13. 13.
    Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63(4):533–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25(34):7754–62. Epub 2005/08/27.CrossRefGoogle Scholar
  15. 15.
    Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007;104(26):11056–61.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature medicine. 2011;17(10):1228–30. Epub 2011/10/04.PubMedCrossRefGoogle Scholar
  17. 17.
    Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron. 2005;46(6):957–69. Epub 2005/06/15.PubMedCrossRefGoogle Scholar
  18. 18.
    Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159(5):728–37.PubMedCrossRefGoogle Scholar
  19. 19.
    Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci. 2008;28(49):13066–74.CrossRefGoogle Scholar
  20. 20.
    Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009;29(4):372–7.CrossRefGoogle Scholar
  21. 21.
    de La Fuente-Fernandez R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, et al. Apomorphine- induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition. J Cereb Blood Flow Metab. 2001;21(10):1151–9.CrossRefGoogle Scholar
  22. 22.
    Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7(6):587–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L. Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol. 2009;587(Pt 15):3869–83.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci. 2009;29(15):4882–7. Epub 2009/04/17.PubMedCrossRefGoogle Scholar
  25. 25.
    Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther. 2011;90(5):651–61.PubMedCrossRefGoogle Scholar
  26. 26.
    Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain. 2001;93(1):77–84.PubMedCrossRefGoogle Scholar
  27. 27.
    Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol. 2004;3(11):679–84.PubMedCrossRefGoogle Scholar
  28. 28.
    Kirk JM, Doty P, De Wit H. Effects of expectancies on subjective responses to oral delta9- tetrahydrocannabinol. Pharmacol Biochem Behav. 1998;59(2):287–93.PubMedCrossRefGoogle Scholar
  29. 29.
    Metrik J, Rohsenow DJ, Monti PM, McGeary J, Cook TA, de Wit H, et al. Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol. 2009;17(4):217–25.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003;23(36):11461–8.PubMedGoogle Scholar
  31. 31.
    Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3(70):70ra14.CrossRefGoogle Scholar
  32. 32.
    Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Meta-analysis of the placebo response in antidepressant trials. Journal of affective disorders. 2009;118(1–3):1–8. Epub 2009/02/28.PubMedCrossRefGoogle Scholar
  33. 33.
    Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Archives of internal medicine. 2006;166(2):155–60. Epub 2006/01/25.Google Scholar
  34. 34.
    Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis care & research. 2010;62(6):791–9. Epub 2010/03/02.CrossRefGoogle Scholar
  35. 35.
    Klinger R. The potential of the analgetic placebo effect - s3-guideline recommendation on the clinical use for acute and perioperative pain management. Anasthesiol Intensivmed Notfallmed Schmerzther.45(1):22–9.Google Scholar
  36. 36.
    Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9(12):39–47.PubMedCrossRefGoogle Scholar
  37. 37.
    Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. Bmj. 2008;336(7651):999–1003.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Doering BK, Rief W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci. 2012;33(3):165–72. Epub 2012/01/31.PubMedCrossRefGoogle Scholar
  39. 39.
    Goebel MU, Meykadeh N, Kou W, Schedlowski M, Hengge UR. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom. 2008;77(4):227–34.PubMedCrossRefGoogle Scholar
  40. 40.
    Sandler AD, Glesne CE, Bodfish JW. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? Journal of developmental and behavioral pediatrics: JDBP. 2010;31(5):369–75. Epub 2010/05/25.PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science. 1982;215(4539):1534–6. Epub 1982/03/19.PubMedCrossRefGoogle Scholar
  42. 42.
    Schedlowski M, Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain, behavior, and immunity. 2010;24(2):176–85. Epub 2009/08/25.Google Scholar
  43. 43.
    Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, et al. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PloS one. 2012;7(10):e48135. Epub 2012/10/31.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    tein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain. 2012;153(11):2210–7. Epub 2012/09/11.CrossRefGoogle Scholar
  45. 45.
    Kong J, Jensen K, Loiotile R, Cheetham A, Wey H-Y, Tan Y, et al. Functional connectivity of frontoparietal network predicts cognitive modulation of pain. Pain. 2012;in press.Google Scholar
  46. 46.
    Hashmi JA, Baria AT, Baliki MN, Huang L, Schnitzer TJ, Apkarian AV. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain. 2012;153(12):2393-402. Epub 2012/09/19.Google Scholar
  47. 47.
    Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, et al. Loss of expectation- related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain. 2006;121(1-2):133–44.PubMedCrossRefGoogle Scholar
  48. 48.
    Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials. Clin Pharmacol Ther. 2011.Google Scholar
  49. 49.
    Laferton JA, Shedden Mora M, Auer CJ, Moosdorf R, Rief W. Enhancing the efficacy of heart surgery by optimizing patients’ preoperative expectations: study protocol of a randomized controlled trial. American heart journal. 2013;165(1):1–7. Epub 2012/12/15.PubMedCrossRefGoogle Scholar

Copyright information

© Urban & Vogel 2014

Authors and Affiliations

  1. 1.Universitätsklinikum Essen, Abteilung für Neurologie, Universität Duisburg-EssenEssenDeutschland

Personalised recommendations